SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-05-011382
Filing Date
2005-01-25
Accepted
2005-01-25 16:07:33
Documents
5
Period of Report
2005-01-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 26740
2 INDENTURE BETWEEN THE COMPANY AND U.S. BANK NATIONAL ASSOCIATION dex41.htm EX-4.1 516847
3 REGISTRATION RIGHTS AGREEMENT dex42.htm EX-4.2 109926
4 PRESS RELEASE DATED JANUARY 25, 2005 dex991.htm EX-99.1 5885
5 GRAPHIC g26443image001.jpg GRAPHIC 13106
  Complete submission text file 0001193125-05-011382.txt   674859
Mailing Address 352 KNOTTER DRIVE CHESHIRE CT 06511
Business Address 352 KNOTTER DRIVE CHESHIRE CT 06511 2037761790
ALEXION PHARMACEUTICALS INC (Filer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-27756 | Film No.: 05547295
SIC: 2834 Pharmaceutical Preparations